(Q43246238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

main subject

hepatocellular carcinoma

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Xiao-Lan Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Bao-Cai Xing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hai-Bo Han

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Wei Zhao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mei-Hao Hu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Zuo-Liang Xu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ji-You Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yong Xie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jun Gu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yu Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

6 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

167-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

Estimating the world cancer burden: Globocan 2000.

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

21 January 2018

Hepatobiliary surgery

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Cancer stem cells: an old idea--a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Characterization of a side population of cancer cells from human gastrointestinal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

The phenotypes of pluripotent human hepatic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Most C6 cells are cancer stem cells: evidence from clonal and population analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Aldehyde dehydrogenase as a marker for stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

PolyADP-ribosylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Liver cancer: the role of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Human hepatic stem cells from fetal and postnatal donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Chemotherapy and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Clonal persistence and evolution during a decade of recurrent melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

(ADP-ribose)n participates in DNA excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP232

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGP232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897602%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference